Ann: Opyl - Commercial Update, page-14

I would assume its put in there because there is no immediate need for a CR...... Looking at the quarterly and the announcement, it sounds to me they got an R&D rebate, COVID business support payments and a few new deals and then in yesterdays announcement it says it should be operating at breakeven or better over the coming quarters. Anyways, that's just how I'm looking at it for now. People that have been burned hard from past management are clearly still bitter - can't change that. I see it as new management and new products so as far as I'm concerned, SRO is a non-event and I'm looking to see how these new markets develops over the next 12-24 months. I think people need to keep in mind how small this company is - and go from there. IMO. Good luck all